Physician profile
Ryan Marks
NPI 1639606239
$1,153.83
in general payments reported to CMS, 2019-2025
16 companies · $89.33 in 2025
The $89.33 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $280 · 2020: $236 · 2021: $66.00 · 2022: $73.71 · 2023: $136 · 2024: $273 · 2025: $89.33.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $498.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $498.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $188.51 | 2024 | Krystexxa |
| Pinnacle, INC | $184.33 | 2019-2020 | |
| Smith+Nephew, INC. | $143.02 | 2019-2022 | |
| Integra Lifesciences Corporation | $140.18 | 2020-2021 | |
| Ani Pharmaceuticals, INC. | $95.25 | 2024-2025 | Purified Cortrophin Gel |
| Paragon 28, INC. | $93.78 | 2019-2021 | |
| Stryker Corporation | $93.41 | 2023-2024 | Variax, Dart-Fire |
| Horizon Therapeutics Plc | $46.32 | 2021-2023 | Krystexxa |
| Nevro Corp. | $32.96 | 2023 | Senza |
| Abbvie INC. | $28.49 | 2022 | |
| Surgenex LLC | $24.29 | 2025 | Ardeograft, Surmatrix, Pellograft |
| Reprise Biomedical, INC. | $22.75 | 2024 | Miro3d |
| Bioventus LLC | $21.82 | 2023 | Exogen Ultrasound Bone Healing System |
| Depuy Synthes Sales INC. | $19.59 | 2019 | |
| Medela LLC | $13.63 | 2020 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Orthofix Medical, INC. | $5.50 | 2025 | Physio-Stim |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Marks listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.